Rob Dickey has more than 25 years experience in entrepreneurial management and in investment banking. Mr. Dickey has been involved in the building and management of high growth companies, in private and public market fundraising, IPO s and mergers and acquisitions and in structuring and negotiating academic collaborations and licensing agreements. Before StemCyte, he was CFO at Locus Pharmaceuticals, Inc. where he raised over $40 million in debt and equity financing and from partnering revenues. Previously, Mr. Dickey was President, CEO and CFO of Protarga, Inc., where he raised more than $55 million, filed a registration statement to take Protarga public and then sold the company to Daiichi Sankyo, Co., Ltd. He began his career on Wall Street spending 13 years at Lehman Brothers in general corporate finance and in the M&A department and then four years as a Managing Director at Legg Mason Wood Walker. Mr. Dickey holds an MBA from The Wharton School, University of Pennsylvania, and a B.A. from Princeton University.